Drugs Industry 'Neglecting' Research on Side-Effects
Posted on: Thursday, 22 September 2005, 06:00 CDT
More than 1,000 patients a year die from the side-effects of medical drugs, despite the existence of genetic tests for patients that could reduce the toll. Patients prescribed drugs face a lottery in which their genetic make-up determines whether they benefit from the treatment or are harmed by side-effects
. But, a report says, pharmaceutical companies are not interested in developing genetic tests, which would reduce sales. The Government and medical charities are also failing to invest in the necessary research. Launching a report on personalised medicines published by the Royal Society, Sir David Weatherall, regius professor of medicine at Oxford University, said the NHS was expected to spend pounds 11bn on drugs in 2005-06. But up to 50 per cent of drugs may not work in the way intended.Source: Independent, The; London (UK)
Related Articles
- Geron Initiates Clinical Trial of Telomerase Inhibitor Drug in Patients With Multiple Myeloma
- FDA Approves Novel Drug AIDS Patients
- Wantagh Man Trying to Persuade Pharmaceutical Companies to Give Him Access to an Experimental Drug: Cancer Patient in a Bind
- Drugs Trial Patients Start to Improve SCIENCE: TESTS
- Drug Trial Patient Reported in Coma
- Glitches in Medicare Prescription Plan Keep Drugs From Patients
- The Immune Response Corporation Cleared to Initiate New IR103 Study in HIV Drug-Naive Patients in Italy; IR103 Clinical Program Expands to 9 Sites in 3 Countries
- MS Hopes Shattered As New Drug Pulled -- 1 Patient Died, Another Developed Serious Nervous System Disease
- The Immune Response Corporation Presents Preliminary Analysis of REMUNE Phase II Trial in HIV Positive, Drug Naive Patients
- AIDS Drugs Change Patients' Looks
Rating: 2.8 / 5 (10 votes)
 |
 |
Rate this article:
User Comments (0)
RSS Feeds